Status:
COMPLETED
Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Conditions:
Malignant Lymphoma
Hodgkin's Disease
Eligibility:
All Genders
8+ years
Brief Summary
Background: The malignant lymphomas, Hodgkin´s disease (HD) and non-Hodgkin´s lymphoma (NHL), comprise approximately 5-6% of all malignancies in adults and account for 10% of childhood cancers. Once ...
Eligibility Criteria
Inclusion
- male or female patients
- age: 8 years and older
- histologically proven Hodgkin's disease or non-Hodgkin's lymphoma
- patients scheduled for a CT of the body for initial staging
- participant's parents (participant \< 18 years) or the participant (participant \>18 years) must willingly give written informed consent prior to the start of the study
- whole-body MRI has to be performed within 10 days before or after CT, and before therapy has been started.
Exclusion
- patients with a general contraindication for MRI (including cardiovascular pacemakers, claustrophobia)
- patients who have had a previous malignancy
- patients who are pregnant or nursing
- patients in whom therapy has already started after CT and before MRI could be performed
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT00685997
Start Date
June 1 2008
End Date
June 1 2012
Last Update
July 3 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Academic Medical Center Amsterdam
Amsterdam, North Holland, Netherlands, 1105 AZ
2
Meander Medical Center Amersfoort
Amersfoort, Utrecht, Netherlands, 3818 ES
3
University Medical Center Utrecht
Utrecht, Utrecht, Netherlands, 3584 CX